Soon, blood test that detects breast cancer many decades in advance
A blood test that can identify women at high risk of breast cancer decades before the disease develops could be available in five years, say scientists.
|Last Updated: May 01, 2012, 11:35 AM IST|Source: Bureau
London: A blood test that can identify women at high risk of breast cancer decades before the disease develops could be available in five years, say scientists.
Scientists at Imperial College London have identified a ‘genetic switch’, carried by one in five women, which doubles their risk of developing breast cancer.
Experts described the breakthrough discovery as “exciting” and said signs of the disease could be detected “many decades in advance”.
Dr James Flanagan, who led the new research, said the test could be available in five to ten years, the Telegraph reported.
The ‘genetic switch’ is influenced by lifestyle factors such as alcohol, smoking, pollution, and hormones including HRT.
Carrying the genetic alterations increase a woman’s lifetime risk of developing breast cancer from one in eight in the general population to one in four.
These tiny genetic changes could be detected in blood samples years before symptoms of breast cancer developed.
Scientists analysed blood samples from 1,380 women of various ages, 640 of whom went on to develop breast cancer.
On average, the blood tests were carried out three years before diagnosis. In some cases they pre-dated the discovery of breast cancer by up to 11 years.
The results were especially clear in blood samples from women under the age of 60.
The changes are also associated with lymphoma and leukaemia meaning the test could have implications in other cancers.
A strong association was found between molecular changes in a white blood cell gene called ATM and breast cancer risk.
“We are working towards prevention. If we can identify women at high risk of cancer we can work towards preventing it and could reduce the incidence of breast cancer quite dramatically,” said Dr Flanagan.
“We have found one marker, we need to work towards finding them all and then we will have a more useful test,” he stated.
Baroness Delyth Morgan, chief executive of Breast Cancer Campaign, said: “Dr Flanagan’s research into epigenetics is so exciting because it suggests that there is every possibility the risk of developing breast cancer could be decided many decades in advance.
“By piecing together how this happens, we can look at ways of preventing the disease and detecting it earlier to give people the best possible chance of survival,” Delyth Morgan added.
The latest findings are published in the journal Cancer Research.
ANI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.